The Unintended Consequences of Clinical Trials Regulations
article has not abstract
Vyšlo v časopise:
The Unintended Consequences of Clinical Trials Regulations. PLoS Med 6(11): e32767. doi:10.1371/journal.pmed.1000131
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000131
Souhrn
article has not abstract
Zdroje
1. StewartPM
StearsA
TomlinsonJW
BrownMJ
2008 Regulation – the real threat to clinical research. BMJ 337 1085 1087
2. 2002 ICH Good Clinical Practice CPMP/ICH/135/95. Available: http://www.emea.europa.eu/pdfs/human/ich/013595en.pdf. Accessed 6 July 2009.
3. BaumM
BuchananM
BaselgaJ
CataliottiL
JassemJ
2007 The future of breast cancer research in danger. Eur J Can 38 2210 2213
4. 2001 Directive 2001/20/ EC of the European parliament and of the council of 4 April 2002 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities L121 34 44 Available: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf. Accessed 6 July 2009.
5. 2004 The Medicines for Human Use (Clinical Trials) Regulations 2004. Available: http://www.opsi.gov.uk/si/si2004/20041031.htm. Accessed 6 July 2009.
6. MHRA website Available: http://www.mhra.gov.uk/index.htm. Accessed 6 July 2009
7. 2005 Commission Directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products. Official Journal of the European Communities L91: 13–19. Available: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2005_28/dir_2005_28_en.pdf. Accessed 6 July 2009.
8. 2005 Draft guidance on ‘specific modalities’ for non-commercial clinical trials referred to in Commission Directive 2005/28/EC laying down the principles and detailed guidelines for good clinical practice. Available: http://ec.europa.eu/enterprise/pharmaceuticals/pharmacos/docs/doc2006/07_2006/guide_noncommercial_2006_07_27.pdf. Accessed 6 July 2009.
9. 2006 Statutory Instrument 2006 No. 1928. The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006. Available: http://www.opsi.gov.uk/si/si2006/20061928.htm. Accessed 6 July 2009.
10. 2006 Statutory Instrument 2006 No. 2984. The Medicines for Human Use (Clinical Trials) Amendment (No. 2) Regulations 2006. Available: http://www.opsi.gov.uk/si/si2006/20062984.htm. Accessed 6 July 2009.
11. 2006 Explanatory Memorandum to the Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 No. 1928. Available: http://www.opsi.gov.uk/si/em2006/uksiem_20061928_en.pdf. Accessed 6 July 2009.
12. 2006 Explanatory Memorandum to the Medicines for Human Use (Clinical Trials) Amendment Regulations 2006 No. 2984. Available: http://www.opsi.gov.uk/si/em2006/uksiem_20062984_en.pdf. Accessed 6 July 2009.
13. Anonymous 2003 Who's afraid of the European Clinical Trials Directive? Lancet 361 2167
14. SullivanR
LawK
2003 Cancer research UK says… Lancet Onc 4 718 719
15. MoriceAH
2003 The death of academic clinical trials. Lancet 361 1568
16. FlavellDJ
FlavellSU
SullivanR
2003 European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287. Lancet 3623 1415
17. Anon 2004 EU clinical trials directive: 0% inspiration, 100% perspiration? Lancet Neur 3 321
18. MeunierF
DuboisN
NegroukA
ReaLA
2003 Throwing a wrench in the works? Lancet Onc 4 717 718
19. WilliamsN
2004 Breast cancer research and the European Union Clinical Trials Directive. Breast Can Res 6 145 147
20. SaghatchianM
TurszT
2003 Organisation of European Cancer Institutes says… Lancet Onc 4 718
21. NundyS
GulhatiCM
2005 A new colonialism? Conducting clinical trials in India. N Engl J Med 352 1633 1636
22. WoodsK
2004 Implementing the European clinical trials directive - Discussions continue in the European Commission and the United Kingdom. BMJ 328 7434 240 241
23. SingerEA
MullnerM
2002 Implications of the EU directive on clinical trials for emergency medicine - Many trials in emergency medicine will not be possible. BMJ 324 1169 1170
24. DrumlC
SingerEA
2004 The European Directive: a further blow to science in intensive care medicine in Austria. Inten Care Med 30 335
25. HallJE
Diaz-NavarroC
2005 Living with the European Clinical Trials Directive: one year on. Anaesthesia 60 949 951
26. BoschX
2005 Europe's restrictive rules strangling clinical research. Nat Med 11 1260
27. HartmannM
Hartmann-VareillesF
2006 The clinical trials directive: how is it affecting Europe's noncommercial research? PLoS Clin Trials 1 e13 doi:10.1371/journal.pctr.0010013
28. SinhaG
2006 European move affects academic trials research. J Nat Can Inst 98 1100 1101
29. HemminkiA
Kellokumpu-LehtinenPL
2006 Harmful impact of EU clinical trials directive - Academic clinical research in cancer seems to have no future in Europe. BMJ 332 501 502
30. RiceM
2006 New data on clinical trials directive in Europe show few favourable outcomes. J Nat Can Inst 98 159 160
31. HanningCD
RentowlP
2006 Harmful impact of EU clinical trials directive - Trial of alerting drug in fibromyalgia has had to be abandoned. BMJ 332 666
32. WatsonM
2006 Harmful impact of EU clinical trials directive … and so has trial of melatonin in cancer related weight loss. BMJ 332 666
33. MitchellCD
2006 Harmful impact of EU clinical trials directive … while paediatric oncology is being scuppered. BMJ 332 666
34. CannellE
2007 Clinical Trials Directive slows registration of paediatric studies. Lancet Onc 8 10
35. WelzingL
HarnischmacherU
WeyersbergA
RothB
2007 Consequences of Directive 2001/20/EC for investigator-initiated trials in the paediatric population - a field report. Eur J Ped; 166 1169 1176
36. MitchellC
2007 Clinical trials in paediatric haematology-oncology: are future successes threatened by the EU directive on the conduct of clinical trials? Arc Dis Child 92 1024 1027
37. European Parliament 2006 EU Regulation 1901/2006. Available: http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2006_1901/reg_2006_1901_en.pdf. Accessed 6 July 2009.
38. LehmannB
2008 Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations. Child Adolesc Psychiatry Ment Health 2 37
39. PermanandG
MossialosE
McKeeM
2007 The EU's new paediatric medicines legislation: serving children's needs? Arc Dis Child 92 808 811
40. HearnJ
SullivanR
2007 The impact of the ‘Clinical Trials’ directive on the cost and conduct of non-commercial cancer trials in the UK. Eur J Can 43 8 13
41. CaliffRM
2007 Clinical trials bureaucracy: unintended consequences of well-intentioned policy. Clin Trials 6 496 502
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2009 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- The Unintended Consequences of Clinical Trials Regulations
- The Link between Dengue Incidence and El Niño Southern Oscillation